Assembly Biosciences ASMB Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.21M-80.7% | $42.47M+294% | $10.79M+12.1% | $9.63M+2.2% | $9.42M+28.0% | ||
| $14.9M-13.6% | $17.25M+4.0% | $16.59M+2.9% | $16.13M+8.6% | $14.85M+4.0% | ||
| $4.68M-13.6% | $5.42M+6.6% | $5.09M+10.7% | $4.59M+1.9% | $4.51M-2.2% | ||
| $19.58M-13.6% | $22.67M+4.6% | $21.67M+4.6% | $20.72M+7.0% | $19.36M+2.5% | ||
| $19.58M-13.6% | $22.67M+4.6% | $21.67M+4.6% | $20.72M+7.0% | $19.36M+2.5% | ||
| -$11.37M— | —— | -$10.88M+1.9% | -$11.09M-11.6% | -$9.94M+13.8% | ||
| -138.4%— | —— | -100.9%+14.4pp | -115.2%-9.7pp | -105.5%+51.2pp | ||
| $2.29M0.0% | $2.29M+35.8% | $1.69M+88.5% | $895K-20.3% | $1.12M+0.2% | ||
| $2.29M0.0% | $2.29M+35.8% | $1.69M+88.5% | $895K-20.3% | $1.12M+0.2% | ||
| -$9.08M— | —— | -$9.2M+9.8% | -$10.2M-15.6% | -$8.82M+14.7% | ||
| -110.5%— | —— | -85.2%+20.7pp | -105.9%-12.3pp | -93.6%+46.9pp | ||
| -$0.54— | —— | -$0.72+45.9% | -$1.33-13.7% | -$1.17+25.5% | ||
| -$0.54— | —— | -$0.72+45.9% | -$1.33-13.7% | -$1.17+25.5% | ||
| 16.9M+50.7% | 11.2M-11.6% | 12.7M+65.7% | 7.7M+2.0% | 7.5M+25.0% | ||
| 16.9M+50.7% | 11.2M-11.6% | 12.7M+65.7% | 7.7M+2.0% | 7.5M+25.0% | ||
| -$9.41M— | —— | -$9.01M+11.9% | -$10.22M-15.4% | -$8.86M+14.7% | ||
| $2.29M0.0% | $2.29M+35.8% | $1.69M+88.5% | $895K-20.3% | $1.12M+0.2% | ||
| -$327K-767% | $49K-74.1% | $189K+827% | -$26K+38.1% | -$42K+23.6% | ||
| —— | $18.08M0.0% | $18.08M0.0% | $18.08M0.0% | $18.08M+154% | ||
| -$11.37M— | —— | -$10.88M+1.9% | -$11.09M-11.6% | -$9.94M+13.8% | ||
| -$11.34M— | —— | -$10.85M+1.9% | -$11.06M-11.6% | -$9.91M+13.8% | ||
| -$11.34M— | —— | -$10.85M+1.9% | -$11.06M-11.6% | -$9.91M+13.8% | ||
| -138.1%— | —— | -100.6%+14.3pp | -114.9%-9.7pp | -105.2%+51.1pp | ||
| -$11.37M— | —— | -$10.88M+1.9% | -$11.09M-11.6% | -$9.94M+13.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Assembly Biosciences's revenue?
- Assembly Biosciences (ASMB) generated $71.1M in revenue over the trailing twelve months, up 121.1% year over year.
- Is Assembly Biosciences profitable?
- Assembly Biosciences is not currently profitable: it reported a net loss of $37.3M over the trailing twelve months, a -103.6% net margin.
- What is Assembly Biosciences's earnings per share?
- Assembly Biosciences's diluted EPS over the trailing twelve months is $-3.76.
- Where does Assembly Biosciences's income statement data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
